Delhi High Court division bench overturns injunction ruling amid genus and species patent controversy
On 24 March 2025, a single judge of the Delhi High Court refused to grant an interim injunction against Natco Pharma for manufacturing a generic version of F Hoffmann-La Roche’s risdiplam – the only oral drug available in India for the treatment of spinal …